An in vitro model of Stroke-Induced Epilepsy: Elucidation of The roles of Glutamate and Calcium in The induction and Maintenance of Stroke-Induced Epileptogenesis

International Review of Neurobiology

Volumn 81, Issue , 2007, Pages 59-84

  DeLorenzo, Robert J ^a,b,c   Sun, David A ^d   Blair, Robert E ^b   Sombati, Sompong ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Department of Biochemistry and Molecular Biophysics University   (United States)

^d VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; GLUTAMIC ACID;

ANIMAL; CEREBROVASCULAR ACCIDENT; EPILEPSY; HUMAN; METABOLISM; PATHOPHYSIOLOGY; REVIEW;

ANIMALS; CALCIUM; CEREBROVASCULAR ACCIDENT; EPILEPSY; GLUTAMIC ACID; HUMANS;

EID: 34047237833     PISSN: 00747742     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0074-7742(06)81005-6     Document Type: Review

References (65)

1. Anderson W.W., Lewis D.V., Swartzwelder H.S., and Wilson W.A. Magnesium-free medium activates seizure-like events in the rat hippocampal slice. Brain Res. 398 (1986) 215-219
2. Bading H. Nuclear calcium-activated gene expression: Possible roles in neuronal plasticity and epileptogenesis. Epilepsy Res. 36 (1999) 225-231
3. Berridge M.J. Neuronal calcium signaling. Neuron 21 (1998) 13-26
4. 2+/calmodulin-dependent protein kinase II activity in a hippocampal neuronal culture model of spontaneous recurrent seizures. Brain Res. 851 (1999) 54-65
5. Bronstein J.M., Farber D.B., and Wasterlain C.G. Regulation of type-II calmodulin kinase: Functional implications. Brain Res. Brain Res. Rev. 18 (1993) 135-147
6. Bullock R., Zauner A., Woodward J., and Young H.F. Massive persistent release of excitatory amino acids following human occlusive stroke. Stroke 26 (1995) 2187-2189
7. Carafoli E., Nicotera P., and Santella L. Calcium signalling in the cell nucleus. Cell Calcium 22 (1997) 313-319
8. Choi D. Stroke. Neurobiol. Dis. 7 (2000) 552-558
9. Choi D.W. Glutamate receptors and the induction of excitotoxic neuronal death. Prog. Brain Res. 100 (1994) 47-51
10. Churn S.B., Anderson W.W., and DeLorenzo R.J. Exposure of hippocampal slices to magnesium-free medium produces epileptiform activity and simultaneously decreases calcium and calmodulin-dependent protein kinase II activity. Epilepsy Res. 9 (1991) 211-217
11. Churn S.B., Kochan L.D., and DeLorenzo R.J. Chronic inhibition of Ca(2+)/calmodulin kinase II activity in the pilocarpine model of epilepsy. Brain Res. 875 (2000) 66-77
12. Conn P.J., and Pin J.P. Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 37 (1997) 205-237
13. Croucher M.J., and Bradford H.F. NMDA receptor blockade inhibits glutamate-induced kindling of the rat amygdala. Brain Res. 506 (1990) 349-352
14. Croucher M.J., Bradford H.F., Sunter D.C., and Watkins J.C. Inhibition of the development of electrical kindling of the prepyriform cortex by daily focal injections of excitatory amino acid antagonists. Eur. J. Pharmacol. 152 (1988) 29-38
15. Davalos A., Castillo J., Serena J., and Noya M. Duration of glutamate release after acute ischemic stroke. Stroke 28 (1997) 708-710
16. Davies J., and Watkins J.C. Actions of D and L forms of 2-amino-5-phosphonovalerate and 2-amino-4-phosphonobutyrate in the cat spinal cord. Brain Res. 235 (1982) 378-386
17. Delgado-Escueta A.V., and Porter R. Symptomatic lesional epilepsies: Introduction. Adv. Neurol. 79 (1999) 433-435
18. DeLorenzo R.J., and Morris T.A. Long-term modulation of gene expression in epilepsy. Neuroscientist 5 (1999) 86-99
19. 2+ transduction pathway causes spontaneous recurrent epileptiform discharges in hippocampal neurons in culture. Proc. Natl. Acad. Sci. USA 95 (1998) 14482-14487
20. DeLorenzo R.J., Sun D.A., and Deshpande L.S. Cellular mechanisms underlying acquired epilepsy: The calcium hypothesis of the induction and maintainance of epilepsy. Pharmacol. Ther. 105 (2005) 229-266
21. Didier M., Heaulme M., Soubrie P., Bockaert J., and Pin J.P. Rapid, sensitive, and simple method for quantification of both neurotoxic and neurotrophic effects of NMDA on cultured cerebellar granule cells. J. Neurosci. Res. 27 (1990) 25-35
22. Dingledine R., McBain C.J., and McNamara J.O. Excitatory amino acid receptors in epilepsy. Trends Pharmacol. Sci. 11 (1990) 334-338
23. Dingledine R., Borges K., Bowie D., and Traynelis S.F. The glutamate receptor ion channels. Pharmacol. Rev. 51 (1999) 7-61
24. Dirnagl U., Iadecola C., and Moskowitz M.A. Pathobiology of ischaemic stroke: An integrated view. Trends Neurosci. 22 (1999) 391-397
25. Furshpan E.J., and Potter D.D. Seizure-like activity and cellular damage in rat hippocampal neurons in cell culture. Neuron 3 (1989) 199-207
26. Ghosh A., and Greenberg M.E. Calcium signaling in neurons: Molecular mechanisms and cellular consequences. Science 268 (1995) 239-247
27. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260 (1985) 3440-3450
28. Hansen A.J., and Nedergaard M. Brain ion homeostasis in cerebral ischemia. Neurochem. Pathol. 9 (1988) 195-209
29. Hardingham G.E., Chawla S., Johnson C.M., and Bading H. Distinct functions of nuclear and cytoplasmic calcium in the control of gene expression. Nature 385 (1997) 260-265
30. Hauser W.A., and Hesdorffer D.C. "Epilepsy: Frequency, Causes, and Consequences." (1990), Demos, New York
31. Hauser W.A., Annegers J.F., and Kurland L.T. Prevalence of epilepsy in Rochester, Minnesota: 1940-1980. Epilepsia 32 (1991) 429-445
32. Hoffmann H., Gremme T., Hatt H., and Gottmann K. Synaptic activity-dependent developmental regulation of NMDA receptor subunit expression in cultured neocortical neurons. J. Neurochem. 75 (2000) 1590-1599
33. Honore T., Davies S.N., Drejer J., Fletcher E.J., Jacobsen P., Lodge D., and Nielsen F.E. Quinoxalinediones: Potent competitive non-NMDA glutamate receptor antagonists. Science 241 (1988) 701-703
34. Hossmann K.A. Viability thresholds and the penumbra of focal ischemia. Ann. Neurol. 36 (1994) 557-565
35. Hyrc K.L., Bownik J.M., and Goldberg M.P. Ionic selectivity of low-affinity ratiometric calcium indicators: mag-Fura-2, Fura-2FF and BTC. Cell Calcium 27 (2000) 75-86
36. Koroshetz W.J., and Furshpan E.J. Seizure-like activity and glutamate receptors in hippocampal neurons in culture. Neurosci. Res. Suppl. 13 (1990) S65-S74
37. Limbrick Jr. D.D., Churn S.B., Sombati S., and DeLorenzo R.J. Inability to restore resting intracellular calcium levels as an early indicator of delayed neuronal cell death. Brain Res. 690 (1995) 145-156
38. Lipton P. Ischemic cell death in brain neurons. Physiol. Rev. 79 (1999) 1431-1568
39. Loscher W., and Schmidt D. New horizons in the development of antiepileptic drugs: The search for new targets. Epilepsy Res. 60 (2004) 77-159
40. Macdonald R.L., and Kelly K.M. Antiepileptic drug mechanisms of action. Epilepsia 34 Suppl. 5 (1993) S1-S8
41. Matsumoto H., and Marsan C.A. Cortical cellular phenomena in experimental epilepsy: Interictal manifestations. Exp. Neurol. 9 (1964) 286-304
42. Mayer M.L., and Westbrook G.L. Permeation and block of N-methyl-D-aspartic acid receptor channels by divalent cations in mouse cultured central neurones. J. Physiol. 394 (1987) 501-527
43. Morris T.A., Jafari N., Rice A.C., Vasconcelos O., and DeLorenzo R.J. Persistent increased DNA-binding and expression of serum response factor occur with epilepsy-associated long-term plasticity changes. J. Neurosci. 19 (1999) 8234-8243
44. Morris T.A., Jafari N., and DeLorenzo R.J. Chronic DeltaFosB expression and increased AP-1 transcription factor binding are associated with the long term plasticity changes in epilepsy. Brain Res. Mol. Brain Res. 79 (2000) 138-149
45. Nelson M.T., French R.J., and Krueger B.K. Voltage-dependent calcium channels from brain incorporated into planar lipid bilayers. Nature 308 (1984) 77-80
46. Pal S., Sombati S., Limbrick Jr. D.D., and DeLorenzo R.J. In vitro status epilepticus causes sustained elevation of intracellular calcium levels in hippocampal neurons. Brain Res. 851 (1999) 20-31
47. Pal S., Limbrick Jr. D.D., Rafiq A., and DeLorenzo R.J. Induction of spontaneous recurrent epileptiform discharges causes long-term changes in intracellular calcium homeostatic mechanisms. Cell Calcium 28 (2000) 181-193
48. Pal S., Sun D., Limbrick D., Rafiq A., and DeLorenzo R.J. Epileptogenesis induces long-term alterations in intracellular calcium release and sequestration mechanisms in the hippocampal neuronal culture model of epilepsy. Cell Calcium 30 (2001) 285-296
49. Parsons J.T., Churn S.B., and DeLorenzo R.J. Chronic inhibition of cortex microsomal Mg(2+)/Ca(2+) ATPase-mediated Ca(2+) uptake in the rat pilocarpine model following epileptogenesis. J. Neurochem. 79 (2001) 319-327
50. Perlin J.B., and DeLorenzo R.J. Calcium and epilepsy. In: Pedley T.A., and Meldrum B.S. (Eds). "Recent Advances in Epilepsy, 5" (1992), Churchill Livingstone, Edinburgh 15-36
51. Platenik J., Kuramoto N., and Yoneda Y. Molecular mechanisms associated with long-term consolidation of the NMDA signals. Life Sci. 67 (2000) 335-364
52. Raza M., Pal S., Rafiq A., and DeLorenzo R.J. Long-term alteration of calcium homeostatic mechanisms in the pilocarpine model of temporal lobe epilepsy. Brain Res. 903 (2001) 1-12
53. Raza M., Blair R.E., Sombati S., Carter D.S., Deshpande L.S., and DeLorenzo R.J. Evidence that injury-induced changes in hippocampal neuronal calcium dynamics during epileptogenesis cause acquired epilepsy. Proc. Natl. Acad. Sci. USA 101 (2004) 17522-17527
54. Rice A.C., and DeLorenzo R.J. NMDA receptor activation during status epilepticus is required for the development of epilepsy. Brain Res. 782 (1998) 240-247
55. Rogawski M.A., and Porter R.J. Antiepileptic drugs: Pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol. Rev. 42 (1990) 223-286
56. Sombati S., and DeLorenzo R.J. Recurrent spontaneous seizure activity in hippocampal neuronal networks in culture. J. Neurophysiol. 73 (1995) 1706-1711
57. Sombati S., Coulter D.A., and DeLorenzo R.J. Neurotoxic activation of glutamate receptors induces an extended neuronal depolarization in cultured hippocampal neurons. Brain Res. 566 (1991) 316-319
58. Stasheff S.F., Anderson W.W., Clark S., and Wilson W.A. NMDA antagonists differentiate epileptogenesis from seizure expression in an in vitro model. Science 245 (1989) 648-651
59. Sun D.A., Sombati S., and DeLorenzo R.J. Glutamate injury-induced epileptogenesis in hippocampal neurons: An in vitro model of stroke-induced "epilepsy.". Stroke 32 (2001) 2344-2350
60. Sun D.A., Sombati S., Blair R.E., and DeLorenzo R.J. Calcium-dependent epileptogenesis in an in vitro model of stroke-induced "epilepsy.". Epilepsia 43 (2002) 1296-1305
61. Sun D.A., Sombati S., Blair R.E., and DeLorenzo R.J. Long-lasting alterations in neuronal calcium homeostasis in an in vitro model of stroke-induced epilepsy. Cell Calcium 35 (2004) 155-163
62. Vandecasteele G., Szabadkai G., and Rizzuto R. Mitochondrial calcium homeostasis: Mechanisms and molecules. IUBMB Life 52 (2001) 213-219
63. Watkins J., and Collingridge G. Phenylglycine derivatives as antagonists of metabotropic glutamate receptors. Trends Pharmacol. Sci. 15 (1994) 333-342
64. Witte O.W., Bidmon H.J., Schiene K., Redecker C., and Hagemann G. Functional differentiation of multiple perilesional zones after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 20 (2000) 1149-1165
65. Wong E.H., Kemp J.A., Priestley T., Knight A.R., Woodruff G.N., and Iversen L.L. The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc. Natl. Acad. Sci. USA 83 (1986) 7104-7108